Forum Replies Created
-
Replies
-
Yes, I learn lots of from GPP course. My starting was from word “stakeholder” and ends at how they are engage by GPP. I learnt How GPP guidelines are important in protocol designing, informed consent, trial related harms, prevention packages. What is CAB/CAG, everything was new for me including online course. Important thing I learnt that honest, transparent communication from both sides, and input of community stakeholder is more essential for success of research.
<span class=”Apple-style-span”>I agree with Phumeza and Jessica’s statement that, GPP implementation do not requires trial phase or participation number but GPP is relevant for every trial at every phase.</span>
I agree with Marie that participants were assigned to do a project will give us better and appropriate idea about it.
I think it will be illegal to prescribe any PrEP before FDA approval. It will be hurry to prescribe any formulation and procedure before FDA approval. Though we got positive results this will be ethical duty of research team to take approval of the product from national authority.
I think visitation will properly work than social media because it remove doubt, and face to face communication will be happen.
To improve referral among HIV trial participants for treatment stakeholder’s research and electronic literacy will be important this will be improve by presentation, and messaging.
<div>
I agree with all of you, and your comments. Stakeholders involvement is important for stakeholders engagements and we will involve stakeholders through respectful communication, improving active participation in research, and hearing their ideas, input. By arranging social gathering, events, some special days community stakeholders will be involve.
</div>
For past participants/stakeholders they will be kept engage by making whats apps groups of all stakeholders, sending them messages, emails on events like (Birthday, anniversary, and festival) so that they will remain attach to the research team. Arrange and sponsor social gathering, events and call past participants, and community members give them information about upcoming research/trial. In between trial all stakeholders are motivated in meeting, interviews to stick with protocol.
In above situation safety of trial participant from physical, and social harm will be important. Meeting of research team with members of night club, night club owner, MSM advocacy groups, and human right groups should be arranged on priority. Information about research, safety about participant can be discuss, and assurance to safety of trial participants will be taken during meeting. Main attention will be given on how rumors will be removed, stigma will be reduced so discussion, advocacy, brainstorm, and advice will be important. Night club owner, and MSM advocacy group will acts as key stakeholders here. Tricks, and tips about how to deal with in situation of violence, and stigma will be given to trial participant, and night club owner.
I agree with Bernice, and Anthonia that trial has not ethical obligation then result should be spurious and unreliable data will not be taken in future consideration. Trial also likely to loose opportunities for future partnership and loose strong relationship with key stakeholders.
I am not getting one thing that Thai government waged a severe and widely publicized campaign against illegal drug use, and Thailand’s narcotics law prohibited the distribution of clean needles, in 2003, and then also BTS was started in June 2005. This means research team, trial sponsor, implementer fail to do formative research, banned clean needles issue was not solved so it became problem for trial, CAB was not taken in consideration, and Thai government policy was not studied. Researcher must be engage stakeholders keeping in consideration areas of trial planning, government policy of respective country, communications, issue management plan.
Excellent line by Anthonia, there must be an amendment to any protocol before and while implementing so nothing like final form. I agree with this statement, protocol development is ongoing process and changes may occurs if issues/ question will be raised by both stakeholders or research team. I think protocol should be accepted, and implemented with respect to time.
We will organize meetings, workshops, public forums, and multimedia to provide opportunity for stakeholders on protocol reviews, and ask to advice on the changes in protocol developments. We will also organize consultation with civil society, and other broad stakeholders at global, regional, national level to obtain the focus input on protocol developments. We will also provide opportunity to local stakeholders to trial design issues and procedures, trial objectives, recruitment strategies, informed consent materials and procedures, reimbursement policies, counseling approaches, follow up procedures, and post trial access to trial products and procedures.
Hello everyone,
I was not engaged any activity related to stakeholders in the past. But In my area social media is very strong In future we will use bulk SMS, Whats apps, Facebook, and other social media to inform the CABs, and stakeholders about research progress. It will produce positive impact on research, communication planning, and engagement strategies by keeping all stakeholders in touch with strong, timely, transparent, and ongoing communication. I thinks on whats apps groups rumors may be produced by some stakeholders in the groups but they can be easily identified and easier to clarify. Its very easy for research team to share information, send key messages, identify and collect feedback from stakeholders. Its fast medium to communicate with stakeholders which produce positive effect on research.
Importance of involvement of one stakeholder over another can be determined by interest, knowledge check about the research, and feedback. I think positive and negative attitude toward the research can differentiate the one stakeholder with others. CAB, CAG plays very important role in providing information about stakeholder so that research team will categories them from one another. Stakeholder mapping tools also help us to categories the different stakeholders on the basis of their importance. We can approach interested stakeholders by using cultural events, NGOs, telephonic conversation, interviews, meetings, media, and past experiences with stakeholders. Some stakeholders are having lots of interest but they can produce less impact on research due to less knowledge about research, If we can respectfully communicate, remove their doubts, motivates them, and increase their research literacy they shows active involvement in the research, lie in one category and fulfill the dream of true stakeholder engagements.
As I told previously we have not done any work related to clinical trial and community stakeholder involvement in formative research but, In future we want to conduct HIV prevention clinical trials. So for Formative research we will first find active community stakeholder who are having interest in research by doing survey at different areas, by conducting interview (telephonic/personal). With these community stakeholders we will organize meeting on topics, we want to conduct HIV prevention clinical trials, we want to do this kinds of research, How it will be beneficial for community, and tries to collect, understand, How much target population are there in community, what are the local norms, cultural and social issues, what are their expectations from research team, and How they are looking towards research. If all things going positive in favors of research and research team, then community advisory groups (CAG) will be formed, and knowledge about research will be deliver to CAG members. Then these trained/ Knowledgeable CAG members collect all information related formative research by visiting school, colleges, temples, mosques, churches, NGOs, different places, and help researcher to produce a community map. I think this will be the potential and meaningful involvement of community stakeholder in formative research activities.
